Advertisement
Combining dual inhibition with anti-PD1 therapy yielded >60% rate of complete tumor regression
Focused ultrasound is paired with ALA to utilize sonodynamic therapy to target cancer cells
Targeting pyrimidine synthesis inhibits GSC self-renewal and tumorigenesis
Drug stimulates an immune response to survivin
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Individual tumor DNA may be key
Advertisement
Advertisement